By Exec Edge Editorial Staff Health insurance premiums have climbed for years. Deductibles have climbed...

By Karen Roman Slate Medicines Inc. said it appointed Kenneth Koblan, PhD, as its new Chief...

By Neal Grabarkewitz Every September, a select group of physician residents and student nurse anesthetists...

By Karen Roman Veraxa Biotech AG (Nasdaq: VRXA) said it appointed Raju Willener as Chief...

By Karen Roman Inventiva S.A. (Nasdaq: IVA) said it designated Chris Benecchi as Chief Operating...

By Mike Sheikh Cocrystal Pharma (NASDAQ: COCP) may look like another undercapitalized, clinical-stage biotech searching for...

By Karen Roman Slate Medicines Inc. said it dosed the first participant in Phase 1...

By Mike Sheikh Parkinson’s Disease has challenged drug developers for generations, but Jupiter Neurosciences (NASDAQ:...

By Karen Roman Fulcrum Therapeutics, Inc. (Nasdaq: FULC) said it is merging with Slate Medicines,...

By Exec Edge Editorial Staff IQVIA (NYSE: IQV) and clinical-stage biopharmaceutical company Medera Inc. announced...